Apolipoprotein E (APOE) genotype, dementia, and memory performance among Caribbean Hispanic versus US populations

Alzheimers Dement. 2023 Feb;19(2):602-610. doi: 10.1002/alz.12699. Epub 2022 Jun 4.

Abstract

Introduction: Apolipoprotein E (APOE) is considered the major susceptibility gene for developing Alzheimer's disease. However, the strength of this risk factor is not well established across diverse Hispanic populations.

Methods: We investigated the associations among APOE genotype, dementia prevalence, and memory performance (immediate and delayed recall scores) in Caribbean Hispanics (CH), African Americans (AA), Hispanic Americans (HA) and non-Hispanic White Americans (NHW). Multivariable logistic regressions and negative binomial regressions were used to examine these associations by subsample.

Results: Our final dataset included 13,516 participants (5198 men, 8318 women) across all subsamples, with a mean age of 74.8 years. Prevalence of APOE ε4 allele was similar in CHs, HAs, and NHWs (21.8%-25.4%), but was substantially higher in AAs (33.6%; P < 0.001). APOE ε4 carriers had higher dementia prevalence across all groups.

Discussion: APOE ε4 was similarly associated with increased relative risk of dementia and lower memory performance in all subsamples.

Keywords: Alzheimer's disease; Blacks; Hispanics/Latinos; Non-Hispanic Whites; admixture; apolipoprotein E; cognitive performance; dementia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alleles
  • Alzheimer Disease* / epidemiology
  • Alzheimer Disease* / genetics
  • Apolipoprotein E4* / genetics
  • Apolipoproteins E / genetics
  • Caribbean Region
  • Female
  • Genotype
  • Hispanic or Latino / genetics
  • Humans
  • Male

Substances

  • Apolipoprotein E4
  • Apolipoproteins E